Cited by 69Hormonal and reproductive studiesGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and Disorders

Androgen replacement therapy in Turner syndrome: a pilot study

Zuckerman-Levin, Nehama, Frolova-Bishara, Tatiana, Militianu, Daniela, Levin, Moshe, Aharon-Peretz, Judith, Hochberg, Ze'ev·2009·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Women with Turner syndrome (TS) have reduced levels of androgens due to ovarian failure. HYPOTHESES: Morbidity associated with TS, such as bone fragility, metabolic changes, obesity, neurocognitive profile, and sexual problems may partly relate to androgen insufficiency and improve on androgen replacement therapy (ART). OBJECTIVES: The objective of the study was to determine the effect of androgens on morbidity in TS. DESIGN: Fourteen TS women (aged 17-27 yr) participated in a randomized, double-blind, placebo-controlled crossover pilot. The study was conducted in a hospital outpatient clinic between December 2001 and July 2004. INTERVENTION: TS patients were on estrogen/progestin replacement therapy. Subjects received oral 1.5 mg methyl testosterone (ART) or placebo for 1 yr and the alternative for another year. MAIN OUTCOME MEASURES: The study compared body composition as a primary outcome, and physiology, biochemistry, visceral fat, cognition, and quality of life (QOL) as secondary outcomes. RESULTS: ART as compared with placebo reduced total cholesterol, triglycerides, and high-density lipoprotein cholesterol. It improved bone mineral density, increased lean body mass, and decreased fat mass. ART improved attention, reaction time, and verbal memory and had no effect on executive functions and spatial cognition. Patients reported improved QOL, including general health, coping with stress, and sexual desire. CONCLUSIONS: Androgen insufficiency plays a role in TS-impaired body composition, neurocognition, and QOL, and these aspects improve with ART, which was safe and effective when given for 1 yr.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-0514

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In one pilot study, androgen replacement therapy compared with placebo reduced total cholesterol, triglycerides, and HDL cholesterol in adolescents/young women with TS.

    “One pilot study by Zuckerman-Levin et al. has looked at testosterone replacement in adolescents/young women with TS and confirmed that androgen replacement therapy (ART), as compared with placebo, reduced total cholesterol, triglycerides, but also HDL cholesterol.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z.
Affiliations
  • Division of Pediatric Endocrinology (N.Z.-L., M.L., Z.H.), Technion-Israel Institute of Technology, Haifa 31096, Israel
  • Technion – Israel Institute of Technology (IL)
  • Meyer Children’s Hospital, Rambam Medical Center, Insitute of Cognitive Neurology (T.F.-B., J.A.-P.), Technion-Israel Institute of Technology, Haifa 31096, Israel
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-12-01
Volume
94
Issue
12
Pages
4820-4827
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2070564732
Cited by
69
References
58
Citations by year
2026: 1 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 3 · 2013: 5 · 2012: 8
FWCI
4.60
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
Turner syndrome, testosterone replacement therapy, androgen deficiency, methyltestosterone, body composition, bone mineral density, lipid profile, neurocognitive function, quality of life, ovarian failure, estrogen-progestin therapy, visceral fat
MeSH terms
Adolescent, Adult, Androgens, Anthropometry, Body Composition, Double-Blind Method, Female, Humans, Lipids, Methyltestosterone, Neuropsychological Tests, Pilot Projects, Quality of Life, Turner Syndrome, Treatment Outcome, Cross-Over Studies, Sexuality, Hormone Replacement Therapy, Testosterone Congeners, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review